Managing perianal Crohn’s fistula in the anti-TNFα era

被引:0
|
作者
P. Tozer
D. W. Borowski
A. Gupta
N. Yassin
R. Phillips
A. Hart
机构
[1] Imperial College London,Fistula Research Unit, St Mark’s Hospital
[2] University Hospital North Tees,undefined
来源
Techniques in Coloproctology | 2015年 / 19卷
关键词
Perianal fistula; Crohn’s disease; Surgery; Biological therapies; Anti-tumour necrosis factor-α;
D O I
暂无
中图分类号
学科分类号
摘要
Perianal fistulas in Crohn’s disease are common and difficult to treat. Their aetiology is poorly understood. Assessment is clinical, endoscopic and radiological, and management is undertaken by a multidisciplinary team of gastroenterologists, surgeons and radiologists. Surgical drainage of the fistula tract system with the placement of loose setons precedes combined therapy with immunosuppressant and anti-TNFα agents in most patients. Proctitis should be rigorously eliminated where possible. Definitive surgical repair is sometimes possible and diversion or proctectomy are occasionally required. Combined medical and surgical management represents a promising avenue for the future.
引用
收藏
页码:673 / 678
页数:5
相关论文
共 50 条
  • [21] Effectiveness of Adalimumab in Perianal Fistulas in Crohn's Disease Patients Naive to Anti-TNF Therapy
    Castano-Milla, Carlos
    Chaparro, Maria
    Saro, Cristina
    Barreiro-de Acosta, Manuel
    Garcia-Albert, Ana M.
    Bujanda, Luis
    Martin-Arranz, Maria D.
    Carpio, Daniel
    Munoz, Fernando
    Mancenido, Noemi
    Garcia-Planella, Esther
    Piqueras, Marta
    Calvet, Xavier
    Cabriada, Jose L.
    Botella, Belen
    Bermejo, Fernando
    Gisbert, Javier P.
    JOURNAL OF CLINICAL GASTROENTEROLOGY, 2015, 49 (01) : 34 - 40
  • [22] The long-term outcome of anti-TNF alpha therapy in perianal Crohn’s disease
    J. Rayen
    T. Currie
    R. B. Gearry
    F. Frizelle
    T. Eglinton
    Techniques in Coloproctology, 2017, 21 : 119 - 124
  • [23] Anti-TNF therapy and Crohn's disease
    Peyrin-Biroulet, L.
    GASTROENTEROLOGIE CLINIQUE ET BIOLOGIQUE, 2008, 32 (05): : 478 - 481
  • [24] Anti-TNF Therapy in Crohn's Disease
    Adegbola, Samuel O.
    Sahnan, Kapil
    Warusavitarne, Janindra
    Hart, Ailsa
    Tozer, Philip
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2018, 19 (08)
  • [25] Anti-TNF treatment of Crohn's disease
    Camoglio, L
    VanDeventer, SJH
    Tytgat, GNJ
    TRENDS IN INFLAMMATORY BOWEL DISEASE THERAPY 1996, 1997, : 111 - 117
  • [26] Anti-TNF antibodies for Crohn's disease
    Camilleri, Michael
    NEW ENGLAND JOURNAL OF MEDICINE, 2007, 357 (16): : 1662 - 1662
  • [27] Anti-TNF agents in Crohn's disease
    Van Assche, G
    Rutgeerts, P
    EXPERT OPINION ON INVESTIGATIONAL DRUGS, 2000, 9 (01) : 103 - 111
  • [28] Anti-TNF therapy for Crohn's disease
    D'Haens, G
    CURRENT PHARMACEUTICAL DESIGN, 2003, 9 (04) : 289 - 294
  • [29] The St Vincent's experience of fistulising perianal Crohn's disease in the anti-TNF-α era
    Basnayake, C.
    He, T.
    Qui, T. B.
    Samyue, T.
    Connell, W.
    Lust, M.
    Brown, S.
    Wright, E.
    Kamm, M.
    Bell, S.
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2016, 31 : 127 - 127
  • [30] Treatment of Perianal Fistulas in Crohn's Disease, Seton Versus Anti-TNF Versus Surgical Closure Following Anti-TNF [PISA]: A Randomised Controlled Trial
    Wasmann, Karin A.
    de Groof, E. Joline
    Stellingwerf, Merel E.
    D'Haens, Geert R.
    Ponsioen, Cyriel Y.
    Gecse, Krisztina B.
    Dijkgraaf, Marcel G. W.
    Gerhards, Michael F.
    Jansen, Jeroen M.
    Pronk, Apollo
    van Tuyl, Sebastiaan A. C.
    Zimmerman, David D. E.
    Bruin, Karlien F.
    Spinelli, Antonino
    Danese, Silvio
    van der Bilt, Jarmila D. W.
    Mundt, Marco W.
    Bemelman, Willem A.
    Buskens, Christianne J.
    JOURNAL OF CROHNS & COLITIS, 2020, 14 (08): : 1049 - 1056